ASHLEY SNYDER: Open Payments
NPI 1689450314 · CLINTON, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,247 in 75 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $778 · 2025 $1,247
Food & beverage: $1,247
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 16 | $238 |
| ABBVIE INC. | 15 | $205 |
| Teva Pharmaceuticals USA, Inc. | 6 | $112 |
| Axsome Therapeutics, Inc. | 5 | $100 |
| Novo Nordisk Inc | 5 | $96 |
| Exact Sciences Corporation | 5 | $89 |
| Lilly USA, LLC | 4 | $67 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $64 |
| Lundbeck LLC | 4 | $63 |
| Alkermes, Inc. | 3 | $58 |
Products named: REXULTI, VRAYLAR, AUSTEDO XR, Auvelity, The Cologuard Plus Collection Kit, CAPLYTA, ARISTADA, Wegovy.
Industry payments across IA — which companies pay providers there.
